logo
Stakeholders discuss commercial potential of oil palm cultivation in Tinsukia

Stakeholders discuss commercial potential of oil palm cultivation in Tinsukia

Time of India15-07-2025
1
2
3
Dibrugarh: The Tinsukia district administration on Tuesday convened a high-level meeting to assess the feasibility and commercial prospects of oil palm cultivation in the district.
Chaired by DC Swapneel Paul at his office, the meeting saw participation from revenue circle officers, agriculture department officials, tea board representatives, small tea growers' associations, agricultural production committees, tea estate managers and satradhikars (monastic heads) of Vaishnavite satras. The collective dialogue reinforced the district's push to expand beyond traditional crops like tea and paddy by introducing oil palm as a viable commercial alternative.
The discussion focused on reviewing the progress of oil palm cultivation in the district, examining both the opportunities and challenges associated with the alternative crop. "The commercial potential of oil palm cultivation in our district is significant and we are committed to exploring every avenue that can benefit our farmers. This initiative represents a strategic diversification opportunity for our agricultural community," Paul said.
Oil palm, a high-yield crop, which is widely cultivated in southeast Asia and parts of South India, has gained attention in Assam due to its economic potential. The plant's crude palm oil (CPO) is used in food processing, cosmetics and biofuels, offering farmers a lucrative market. Centre's National Mission on Edible Oils – Oil Palm (NMEO-OP), which promotes domestic oilseed production to reduce imports, has further incentivised its adoption.
The crop, which thrives in tropical conditions, offers promising returns for farmers, while contributing to national food security objectives.
Following the meeting, officials indicated that detailed action plans will be developed to support interested farmers in transitioning to oil palm cultivation.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Consumers are now actively seeking generic substitutes for branded medicines: Sujit Paul, Zota Healthcare
Consumers are now actively seeking generic substitutes for branded medicines: Sujit Paul, Zota Healthcare

Time of India

time7 hours ago

  • Time of India

Consumers are now actively seeking generic substitutes for branded medicines: Sujit Paul, Zota Healthcare

Live Events Awareness of generic medicines has grown substantially, especially among middle-class and elderly populations in recent years, according to Sujit Paul , Group CEO, Zota Healthcare . He notes that today's consumers are more informed and price-conscious and increasingly trust quality-tested generics as reliable alternatives to branded an interaction with, Paul says that people are now proactively asking for generic substitutes, reflecting growing confidence in their efficacy and affordability. This behavioural transformation, he believes, is a foundational step toward building a healthier and more financially secure India. Edited excerpts:Despite global interruptions, the healthcare sector in India has demonstrated remarkable resilience and adaptability. In the face of geopolitical tussles and supply chain disruptions, India has once again positioned itself as a reliable healthcare destination. India, eventually, has shifted its narrative from Make in India to Atmanirbhar Bharat, focusing on investment in infrastructure and diagnostics, research & diagnostics, and the domestic production of Active Pharmaceutical Ingredients (APIs).Aligning itself with this vision, Zota Health Care is strengthening its backward integration and forging strategic partnerships to reduce import India is still the world's biggest seller of inexpensive generic drugs, changing global standards, IP struggles, and over-dependence on imported APIs warrant some concerns. We feel that harmonisation of regulatory standards, both in India and with the global standards, will also reduce compliance burdens while not compromising on safety. On the IP front, we seek a balanced approach that protects innovation while ensuring public health are also looking for a balanced approach on the IP side. The government's assistance in creating indigenous API manufacturing through bulk drug parks and PLI schemes is praiseworthy. We hope the present stability in policies, faster approvals from regulatory bodies, and sustained R&D support will, in turn, help strengthen domestic pharma companies like us to drive innovation and scale has worked hard to create a new vision for self-reliance by strengthening internal capabilities to develop critical APIs and formulations. We are looking at tie-ups for joint R&D in bulk-drug parks and are investing in backward integration for reducing the dependency on imported APIs. This contributes to our larger goal of ensuring cost-effective, high-quality medicines across our brands, especially DavaIndia . Our approach is aimed at building rugged supply chains, cutting down lead times, and passing on these cost benefits to the end consumer without compromising on therapeutic presence is our strength. In a healthcare landscape that keeps evolving, the consumer expects more than medicines; they expect holistic well-being. We have carefully strategised to position our offerings along this continuum of care. While our price-oriented generics business provides affordability, our nutraceutical and ayurveda segments address solutions for preventive care. We work through strong compliance measures, extensive market research, and patient-centric formulations. Through DavaIndia, we have tried to build an integrated platform where all these categories can coordinate under one roof and make these healthcare options not just affordable but have witnessed a perceptible shift in consumer behaviour over the past year. Awareness about generic medicines has grown significantly, especially among the middle class and elderly segments. People are now more informed and price-conscious, and trust quality-tested generics as effective alternatives to branded drugs. Consumers are now proactive in asking for generic substitutes, which is a welcome change. We believe this behavioural shift is fundamental to creating a healthier, financially secure India.

Indonesia expects palm oil exports to India to exceed 5 mn-tonnes mark in 2025: IPOC Chairman
Indonesia expects palm oil exports to India to exceed 5 mn-tonnes mark in 2025: IPOC Chairman

Time of India

timea day ago

  • Time of India

Indonesia expects palm oil exports to India to exceed 5 mn-tonnes mark in 2025: IPOC Chairman

Indonesia expects palm oil exports to India to exceed the 5 million-tonnes mark in 2025, up from 4.8 million tonnes in 2024, following India's decision to cut import tariffs, a senior industry official said. The world's top palm oil producer is also shipping 100,000 germinated palm seeds to India this year to support the South Asian nation's ambitious plan to expand palm cultivation to 1 million hectares by 2025-26, Indonesia Palm Oil Council (IPOC) chairman Eddy Martono told PTI in an interview. Explore courses from Top Institutes in Please select course: Select a Course Category Data Science Leadership MBA Product Management Finance Degree Others Artificial Intelligence Data Analytics Healthcare healthcare Management CXO others Project Management MCA Design Thinking Operations Management Data Science PGDM Public Policy Cybersecurity Digital Marketing Technology Skills you'll gain: Data Analysis & Interpretation Programming Proficiency Problem-Solving Skills Machine Learning & Artificial Intelligence Duration: 24 Months Vellore Institute of Technology VIT MSc in Data Science Starts on Aug 14, 2024 Get Details Skills you'll gain: Strategic Data-Analysis, including Data Mining & Preparation Predictive Modeling & Advanced Clustering Techniques Machine Learning Concepts & Regression Analysis Cutting-edge applications of AI, like NLP & Generative AI Duration: 8 Months IIM Kozhikode Professional Certificate in Data Science and Artificial Intelligence Starts on Jun 26, 2024 Get Details "After the decrease in import tariffs, Indonesia palm oil imports will increase in 2025. I expect it to be more than 5 million tonnes," Martono said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now India lowered basic customs duty on crude palm oil to 10 per cent, from 20 per cent, as part of efforts to boost domestic edible oil availability and control prices. Indonesia's palm oil exports to India fell to 4.8 million tonnes in 2024 calendar year, from 6 million tonnes in 2023, partly due to higher palm oil prices compared to soybean and sunflower oils for most of 2024. Live Events However, palm oil prices have traded below soybean oil since April 2025, improving competitiveness. "I think there is no problem with the price this year. In 2025, I am sure we will increase exports to India," Martono said. India is ramping up palm seed imports as part of its National Mission on Edible Oils-Oil Palm (NMEO-OP), which aims to expand cultivation from the current 350,000 hectares to 1 million hectares by 2025-26. The country purchased about 500,000 seeds in 2023 and 2024 combined, with 100,000 more expected this year, Martono said. About 200 palm seeds are required for cultivation per hectare. Indonesia supports palm seed exports to India through business-to-business arrangements and can provide technical guidance given its experience in palm cultivation, he added. IPOC and the Indian Vegetable Oil Producers' Association (IVPA) recently signed a Memorandum of Understanding to enhance collaboration in the palm oil sector. "India is a very important market for Indonesia. Hope to see stable exports to India after the MoU," Martono said. The partnership also aims to address consumer concerns about palm oil's health impacts in India. "Consumers in India still have misconceptions about Indonesian palm oil. Palm oil is very healthy oil," Martono said, adding that IPOC is collaborating with IVPA to counter negative campaigns about Indonesian palm oil. India is the world's largest importer and consumer of edible oils.

Farmers hurt by low soybean prices shift to maize, lured by rising demand for ethanol
Farmers hurt by low soybean prices shift to maize, lured by rising demand for ethanol

Mint

timea day ago

  • Mint

Farmers hurt by low soybean prices shift to maize, lured by rising demand for ethanol

New Delhi: The government's aim of reducing agricultural imports and making the country self-sufficient in oilseeds seems to be facing setbacks this kharif season due to unremunerative prices for farmers and growing demand for ethanol. The area on which import-dependent crops such as oilseeds is sown has declined, according to data from the Ministry of Agriculture and Farmers Welfare on 25 July. The area under oilseeds dropped by 383,000 hectares from last year. The fall in oilseeds sowing is mainly due to a sharp decline in the cultivation of soybean — India's main kharif oilseed crop — although there were small increases in areas under groundnut and sesamum. The total area of oilseeds cultivation dipped 2% to 16.7 million hectares, primarily due to fall in soybean area by 3.8% to 11.7 million hectares. Soybean constitutes 65% of the total area under oilseeds. Farmers said market prices are lower than the minimum support price (MSP) that the government offers to purchase soybean. However, unlike for paddy or wheat, there's no large-scale procurement infrastructure for soybean. In some states, state-run agencies may buy soybean under a price support scheme, but these are limited in scope and budget. These factors force soybean farmers to switch to crops like maize, which offers better marketability. 'For an acre, the input cost varies from ₹18,000 to ₹20,000, and the production ranges between 5-6 quintals per acre, while the market price of one quintal of soybean was between ₹4,000 and ₹4,100 — which was much below the MSP (minimum support price) of ₹4,892 for crop year 2024-25," said Ganesh Nanote, a soybean farmer from Vidarbha in Maharashtra. Although the government increased the MSP of soybean to ₹5,328/quintal on 28 May, it still failed to attract farmers to cultivate the key oilseed. Ethanol blending 'Since maize is in demand and has higher saleability than soybean, farmers are diversifying towards maize production due to its demand in the ethanol blending programme," said Nanote. India blends as much as 20% of ethanol—a byproduct of some crops—in petrol to reduce carbon emissions from use of the automobile fuel. The decline in oilseed output comes even after repeated government efforts to boost domestic production and reduce import dependence, especially after recent global supply disruptions caused edible oil prices to rise. India imports over 60% of its edible oil needs and has targeted expanded cultivation under the National Mission on Edible Oils – Oil Palm. Apart from the farmers, the edible oil processing industry also faces pressure as shrinking margins due to lower oilmeal prices and uneven supply of oilseeds make it harder to operate at scale. Industry executives argued that unless oilseed cultivation is made economically viable for farmers through targeted support and stable pricing, supply-side constraints will continue to hurt both producers and processors. 'In Punjab, farmers initially picked up sunflower cultivation, but the prices were not remunerative, so they stopped," said A.R. Sharma, chairman of the Sangrur (Punjab)-based Ricela Group of Companies, which processes rice bran oil. 'Secondly, maize is widely used as a feedstock for ethanol in recent years. This has led to increased availability of distillers dried grains with solubles (DDGS), a by-product of ethanol production, primarily from maize, which is widely used in the cattle and poultry industry." The increased availability of DDGS has affected demand for traditional oilmeals and has led to a significant drop in their prices and as a result, processors are finding it difficult to offer farmers a remunerative price, Sharma added. Blow for farmers 'Last year (2024-25), the prices were not good, so we switched to maize this year as it offers better returns. The decline in earnings from soybean, coupled with rising input costs, has affected farmers badly, leading many of them to diversify," said Mahesh Kumar, a farmer from Morena in Madhya Pradesh. According to him, non-remunerative prices have come as a significant blow, especially for small and marginal farmers. Production of oilseeds stood at 41.35 million tonnes in FY23, which decreased to 39.9 million tonnes in FY24 before rising to 42.6 million tonnes in FY25. Soybean production was 14.98 million tonnes in FY23, 13.06 million tonnes in FY24, and 15.18 million tonnes in FY25. Queries sent to the ministry of agriculture remained unanswered. Cotton, a key crop for both the government's self-reliance plan and the textile industry, was sown on 10.3 million hectares as on 25 July compared with 10.5 million hectares last year. In the case of cotton sowing, Nanote — who diversified from cotton to soybean initially and is now shifting to maize — said labour shortages, poor price realisation, and outdated seed technology have pushed him to opt for other crops. The MSP of cotton for the 2025-26 crop year was increased to ₹7,710 per quintal from ₹7,121 per quintal for medium-staple cotton, and to ₹8,110 per quintal from ₹7,521 per quintal for long-staple cotton. India's cotton production stood at 33.66 million bales in FY23, declined to 32.52 million bales in FY24, and further dropped to 30.69 million bales in FY25. (1 bale = 170 kg).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store